A new malaria vaccine could be a 'huge deal' in the fight to save lives in Africa and abroad
Ghana is the first country in the world to approve the R21/Matrix-M vaccine from the University of Oxford. Since then, Nigeria has conditionally approved the vaccine, and other African countries may follow suit — but WHO's yet to approve it. (Source: CBC | Health)
Source: CBC | Health - April 24, 2023 Category: Consumer Health News Tags: Radio/The Current Source Type: news
The Last Mile to Malaria Elimination: Confronting Gender Inequalities & Power Dynamics
In conclusion, achieving malaria elimination through people-centred approaches requires a holistic approach that actively considers issues of gender, intersectionality, and balance of power. It is crucial to ensure that these approaches do not perpetuate existing inequalities, but instead centre the experiences and knowledge of marginalized groups.
By acknowledging and addressing the ways in which different forms of oppression intersect and compound to create experiences of marginalization and exclusion, we can make meaningful strides towards malaria elimination.
To achieve this, sustaining a commitment to inclusivity, eq...
Source: IPS Inter Press Service - Health - April 24, 2023 Category: International Medicine & Public Health Authors: Arthur Ngetich Kipkemoi Saitabau Tags: Africa COVID-19 Development & Aid Featured Gender Global Governance Headlines Health Human Rights Inequity TerraViva United Nations IPS UN Bureau Source Type: news
News at a glance: A new malaria vaccine, a Parkinson ’s test, and editors resign
BIOMEDICINE
Early test for Parkinson’s disease
A large study has shown that a test can indicate a person has Parkinson’s disease before they start having symptoms. The chronic degenerative disease currently lacks a definitive biochemical test. A research team recruited 1123 participants, some of whom had symptoms of Parkinson’s, and used spinal taps to measure their levels of a protein called alpha-synuclein, which clumps and damages brain cells in people with the disease. Study participants whose alpha-synuclein clumped to an extent above a threshold level were deemed to have Parkinson’s. In...
Source: ScienceNOW - April 20, 2023 Category: Science Source Type: news
Nigeria: Malaria Vaccine - What to Know About Life-Changing R21
[Premium Times] It is reported that the 2021 results from the Phase-IIb trial reported that R21/Matrix-M demonstrated high-level efficacy of 77 per cent. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 19, 2023 Category: Infectious Diseases Source Type: news
Nigeria: NAFDAC Approves Clinical Malaria Vaccine for Children
[This Day] Abuja -- The National Agency for Food and Drug Administration and Control (NAFDAC) has granted registration approval for R21 Malaria Vaccine (Recombinant, Adjuvanted). (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 18, 2023 Category: African Health Source Type: news
Nigeria: Hope for Millions As Nigeria Approves Malaria Vaccine
[Premium Times] Similar to Ghana, Mrs Adeyeye said the vaccine is indicated for the prevention of malaria in children from 5 months to 36 months of age. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 18, 2023 Category: Infectious Diseases Source Type: news
Nigeria: Hope Rises for Nigerian Children As Federal Govt Okays Oxford Malaria Vaccine
[Leadership] The provisional approval for R21/Matrix malaria vaccine by the federal government has raised hope in Nigeria. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 18, 2023 Category: Infectious Diseases Source Type: news
Nigeria: Nigeria Approves Malaria Vaccine
[This Day] Abuja -- National Agency For Food And Drug Administration And Control (NAFDAC) has granted registration approval for R21 Malaria Vaccine (Recombinant, Adjuvanted). (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 18, 2023 Category: Infectious Diseases Source Type: news
Nigeria: Federal Govt Grants Provisional Approval for Oxford Malaria Vaccine
[Leadership] The federal government of Nigeria has granted provisional approval for the R21/Matrix malaria vaccine developed by the Oxford University. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 18, 2023 Category: Infectious Diseases Source Type: news
Uganda: Vaccine Against Malaria in Children Gets Approval
[Independent (Kampala)] Kampala -- Ghana on April 13 became the first country to approve public usage of a new experimental vaccine for children to protect them from malaria. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 17, 2023 Category: Infectious Diseases Source Type: news
Ghana: Ghana First to Approve Oxford's 'World Changer' Malaria Vaccine
[VOA] Accra -- Ghana has become the first country to approve a new malaria vaccine described as a "world changer" by scientists who developed it at the University of Oxford. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 14, 2023 Category: Infectious Diseases Source Type: news
Ghana: Ghana First to Approve New Oxford's R21 Vaccine Against Malaria
[Premium Times] Children are at higher risk of the mosquito-borne disease which kills more than 600,000 people each year, according to WHO African Region. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 14, 2023 Category: African Health Source Type: news
Promising new malaria vaccine for kids approved in Ghana
Ghana became the first country to approve a new malaria vaccine for young children that may offer better protection against the disease that kills hundreds of thousands every year (Source: ABC News: Health)
Source: ABC News: Health - April 13, 2023 Category: Consumer Health News Tags: Health Source Type: news
Oxford malaria vaccine wins first regulatory approval from Ghana
Research found booster dose of R21 showed efficacy as high as 80% in one group, and 70% in another (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 13, 2023 Category: Pharmaceuticals Source Type: news
Ghana is first country to approve Oxford malaria vaccine
Ghana has become the first country to approve a highly effective malaria vaccine developed at Oxford university in the UK. The R21/Matrix-M vaccine, the first to exceed the World Health Organization’s target of 75% efficacy, has been cleared for use by Ghana’s Food and Drugs Authority in children…#ghana #oxforduniversity #r21matrixm #profadrianhill #jennerinstitute #nuffielddepartment #oxford #africa #r21 #adarpoonawalla (Source: Reuters: Health)
Source: Reuters: Health - April 13, 2023 Category: Consumer Health News Source Type: news
